EPIDEMIOLOGY OF PANCREATIC CANCER

  • Belma Muratović Faculty of Medicine, University of Belgrade, Belgrade, Republic of Serbia
  • Aleksandra Nikolić Institute of epidemiology, Faculty of Medicine, University of Belgrade, Belgrade, Republic of Serbia
Keywords: pancreatic cancer, incidence, mortality, risk factors, survival, prevention

Abstract


Pancreatic cancer is the seventh leading cause of cancer-related deaths and the twelfth most common cancer worldwide. Incidence and mortality rates vary from country to country, which is a consequence of exposure to different risk factors, the possibilities of early diagnosis and timely and adequate treatment. It is estimated that by 2040, there will be a further increase in the number of patients (e.g. by 27.4% in Europe) and deaths (e.g. by 28.5% in Europe) caused by pancreatic cancer. According to the National Cancer Institute of the United States of America, the average five-year survival rate for pancreatic cancer is 12%. Modifiable and non-modifiable factors contribute to the occurrence of this tumor. Pancreatic cancer occurs more often in the elderly, men, tobacco and alcohol users, people with diabetes, chronic pancreatitis, physically inactive and obese people, as well as in people with a positive family history of this malignant tumor. It is necessary to work on educating the population about the risk factors for pancreatic cancer, the possibilities of prevention and ways of early diagnosis of this disease.

References

Cancer today [Internet]. [ciInstitut za epidemiologiju, Medicinski fakultet, Univerzitet u Beogradu, Beograd, Republika Srbijated 2023 Nov 2]. Available from: http://gco.iarc.fr/today/home

Rawla P, Sunkara T, Gaduputi V. Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. World J Oncol. 2019;10(1):10–27.

Bosetti C, Levi F, Ferlay J, Garavello W, Lucchini F, Bertuccio P, et al. Trends in oesophageal cancer incidence and mortality in Europe. Int J Cancer. 2007;122(5):1118–29.

Klein AP, Brune KA, Petersen GM, Goggins M, Tersmette AC, Offerhaus GJA, et al. Prospective Risk of Pancreatic Cancer in Familial Pancreatic Cancer Kindreds. Cancer Research. 2004;64(7):2634–8.

Hidalgo M, Cascinu S, Kleeff J, Labianca R, Löhr JM, Neoptolemos J, et al. Addressing the challenges of pancreatic cancer: future directions for improving outcomes. Pancreatology. 2015;15(1):8–18.

SEER [Internet]. [cited 2023 Nov 3]. Cancer of the Pancreas - Cancer Stat Facts. Available from: https://seer.cancer.gov/statfacts/html/pancreas.html

Zhang L, Sanagapalli S, Stoita A. Challenges in diagnosis of pancreatic cancer. World J Gastroenterol. 2018;24(19):2047–60.

Mohammed S, Van Buren II G, Fisher WE. Pancreatic cancer: Advances in treatment. World J Gastroenterol. 2014;20(28):9354–60.

MaligniTumoriuRepubliciSrbiji2020.pdf [Internet]. [cited 2023 Nov 2]. Available from: https://www.batut.org.rs/download/publikacije/MaligniTumoriuRepubliciSrbiji2020.pdf

Ezzati M, Henley SJ, Lopez AD, Thun MJ. Role of smoking in global and regional cancer epidemiology: Current patterns and data needs. International Journal of Cancer. 2005;116(6):963–71.

Mathers CD, Fat DM, Inoue M, Rao C, Lopez AD. Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull World Health Organ. 2005;83(3):171–7.

Muratović B, Nikolić A, Šipetić-Grujičić S. Trends in incidence and mortality from pancreatic cancer in Central Serbia, in the period from 1999 to 2019. Zdravstvena zaštita. 2022;51(1):23–38.

Oberstein PE, Olive KP. Pancreatic cancer: why is it so hard to treat? Therapy Adv Gastroenterol. 2013;6(4):321–37.

Cancer Tomorrow [Internet]. [cited 2023 Nov 2]. Available from: https://gco.iarc.fr/tomorrow/en/dataviz/bars?types=0&sexes=0&mode=population&group_populations=0&multiple_populations=1&multiple_cancers=0&cancers=13&populations=903_904_905_908_909_935&single_unit=100

Lucenteforte E, La Vecchia C, Silverman D, Petersen GM, Bracci PM, Ji BT, et al. Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case–Control Consortium (PanC4). Ann Oncol. 2012;23(2):374–82.

Arslan AA, Helzlsouer KJ, Kooperberg C, Shu XO, Steplowski E, Bueno-de-Mesquita HB, et al. Anthropometric Measures, Body Mass Index and Pancreatic Cancer: a Pooled Analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med. 2010;170(9):791–802.

Larsson SC, Wolk A. Red and processed meat consumption and risk of pancreatic cancer: meta-analysis of prospective studies. Br J Cancer. 2012;106(3):603–7.

Appleby PN, Crowe FL, Bradbury KE, Travis RC, Key TJ. Mortality in vegetarians and comparable nonvegetarians in the United Kingdom123. Am J Clin Nutr. 2016;103(1):218–30.

Maisonneuve P, Lowenfels AB. Risk factors for pancreatic cancer: a summary review of meta-analytical studies. International Journal of Epidemiology. 2015;44(1):186–98.

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2018;68(6):394–424.

Hu JX, Zhao CF, Chen WB, Liu QC, Li QW, Lin YY, et al. Pancreatic cancer: A review of epidemiology, trend, and risk factors. WJG. 2021;27(27):4298–321.

Lucas AL, Kastrinos F. Screening for Pancreatic Cancer. JAMA. 2019;322(5):407–8.

Kuroczycki-Saniutycz S, Grzeszczuk A, Zwierz ZW, Kołodziejczyk P, Szczesiul J, Zalewska-Szajda B, et al. Prevention of pancreatic cancer. Contemp Oncol (Pozn). 2017;21(1):30–4.

Published
2023/12/14
Section
Review article